The Pharma Legal Handbook: Luxembourg

Luxembourg is a small but commercially important pharmaceutical market, home to a number of major pharmaceutical company headquarters and a significant hub for pharmaceutical distribution and logistics in Europe. The regulatory framework is administered by the Division of Pharmacy and Medicines of the Ministry of Health, with product authorisation following EU pathways.

Luxembourg's reimbursement system, administered by the National Health Fund (CNS), covers a wide range of pharmaceutical products with a well-defined positive list and co-payment structure. Given Luxembourg's role as a corporate and distribution hub, companies also need to understand the specific rules around parallel imports, wholesale distribution authorisations, and pan-European supply chain obligations.

The Pharma Legal Handbook: Luxembourg provides comprehensive guidance on pharmaceutical regulation in Luxembourg, covering product authorisation, CNS reimbursement pathways, clinical trial requirements, pharmacovigilance obligations, manufacturing and distribution standards, marketing rules, and intellectual property protection.